HarryG. M. Heijerman

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

C. Teneback, P. Sosnay, R. Klingsberg, 2019, The Lancet.

Photosensitivity due to ambulatory intravenous ceftazidime in cystic fibrosis patient

S. Vinks, W. Bakker, HarryG. M. Heijerman, 1993, The Lancet.

Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years.

C. Lamers, H. Heijerman, W. Bakker, 1995, Thorax.

The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort

H. D. de Valk, B. Luijk, HarryG. M. Heijerman, 2023, Clinics.

A cystic fibrosis mutation associated with mild lung disease.

A. V. D. van den Ouweland, H. Scheffer, D. Halley, 1995, The New England journal of medicine.

Journal of Cystic Fibrosis

A. Kraneveld, A. Neerincx, C. Majoor, 2022 .

Journal of Cystic Fibrosis

A. Kraneveld, C. Castellani, I. Sermet-Gaudelus, 2022 .

Pediatric Pulmonology

C. Majoor, H. Arets, M. Eerden, 2019 .